Conversely, the correction of mutant PTPN11 in JMML-IPSCs via gene editing was shown to decrease the output of CD34+ hematopoietic progenitor cells to a level comparable with WT-IPSCs [21]. The gene discussed is CD34; the disease is juvenile myelomonocytic leukemia.